# Influence of Perfluorohexyloctane (NovaTears) on Tear Film Thickness in Patients With Mild to Moderate Dry Eye Disease

> **NCT03048526** · NA · COMPLETED · sponsor: **Novaliq GmbH** · enrollment: 48 (actual)

## Conditions studied

- Dry Eye Disease

## Interventions

- **DEVICE:** NovaTears®
- **DEVICE:** Hydrabak®

## Key facts

- **NCT ID:** NCT03048526
- **Lead sponsor:** Novaliq GmbH
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-12-15
- **Primary completion:** 2017-04-18
- **Final completion:** 2017-04-18
- **Target enrollment:** 48 (ACTUAL)
- **Last updated:** 2017-07-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03048526

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03048526, "Influence of Perfluorohexyloctane (NovaTears) on Tear Film Thickness in Patients With Mild to Moderate Dry Eye Disease". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT03048526. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*